The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2021
Filed:
Aug. 12, 2020
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Guozhang Xu, Chesterbrook, PA (US);
Micheal Gaul, Yardley, PA (US);
Shyh-Ming Yang, Doylestown, PA (US);
Tianbao Lu, Churchville, PA (US);
Rui Zhang, Belle Mead, NJ (US);
Fengbin Song, Doylestown, PA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/04 (2006.01); C07D 231/56 (2006.01); C07D 401/06 (2006.01); C07D 405/14 (2006.01); C07D 405/04 (2006.01); A61K 31/416 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
C07D 231/56 (2013.01); A61K 31/416 (2013.01); C07D 401/06 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01);
Abstract
The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.